Skip to main content
SpringerLink
Log in

Prevention of Proliferative Vitreoretinopathy

  • Chapter
Vitreo-retinal Surgery

Part of the book series: Essentials in Ophthalmology ((ESSENTIALS))

  • 616 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 159.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 209.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Andenmatten R, Gonvers M (1993) Sophisticated vitreoretinal surgery in patients with a healthy fellow eye. Graefes Arch Ophthalmol 231:495–499

    Article  CAS  Google Scholar 

  2. Asaria RHY, Kon CH, Bunce C, Charteris DG, Wong D, Khaw PT, Aylward GW (2001) Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy: results from a randomized, double-blind, controlled clinical trial. Ophthalmology 108:1179–1183

    Article  PubMed  CAS  Google Scholar 

  3. Asaria RH, Kon CH, Bunce C, Charteris DG, Wong D, Luthert PJ, Khaw PT, Aylward GW (2001) How to predict proliferative vitreoretinopathy: a prospective study. Ophthalmology 108:1184–1186

    Article  PubMed  CAS  Google Scholar 

  4. Binder S, Bonnet M, Velikay M, Gerard JP, Stolba U, Wedrich A, Hohenberg H (1994) Radiation therapy in proliferative vitreoretinopathy: a prospective randomized study. Graefes Arch Clin Exp Ophthalmol 232:211–214

    Article  PubMed  CAS  Google Scholar 

  5. Blumenkranz MS, Ophir A, Claflin AJ, Hajek A (1982) Fluorouracil for the treatment of massive periretinal proliferation. Am J Ophthalmol 94:458–467

    PubMed  CAS  Google Scholar 

  6. Blumenkranz M, Hernandez E, Ophir A, Norton E (1984) 5-Fluorouracil: New applications in complicated retinal detachment for an established antimetabolite. Ophthalmology 91:122–130

    PubMed  CAS  Google Scholar 

  7. Bonnet M (1988) The development of severe proliferative vitreoretinopathy after retinal detachment surgery: grade B: a determining risk factor. Graefes Arch Ophthalmol 226:201–205

    Article  CAS  Google Scholar 

  8. Bonnet M, Fleury J, Guenoun S, Yaniali A, Dumas C, Hajjar C (1996) Cryopexy in primary rhegmatogenous retinal detachment: a risk factor for postoperative proliferative vitreoretinopathy? Graefes Arch Clin Exp Ophthalmol 234:739–743

    Article  PubMed  CAS  Google Scholar 

  9. Campochiaro PA, Kaden IH, Vidaurri-Leal J Glaser BM (1985) Cryotherapy enhances intravitreal dispersion of viable retinal pigment epithelial cells. Arch Ophthalmol 103:434–436

    PubMed  CAS  Google Scholar 

  10. Cardillo JA, Stout T, LaBree L, Azen S, Omphroy L, Cui ZJ, Kimura H, Hinton RD, Ryan SJ (1997) Post-traumatic proliferative vitreoretinopathy: The epidemiologic profile, onset, risk factors, and visual outcome. Ophthalmology 104:1166–1173

    PubMed  CAS  Google Scholar 

  11. Cassidy L, Barry P, Duffy J, Kennedy S (1998) Platelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disorders. Br J Ophthalmol 82:181–185

    PubMed  CAS  Google Scholar 

  12. Chang S, Lincoff H, Zimmerman NJ, Fuchs W (1989) Giant retinal tears. Surgical techniques and results using perfluorocarbon liquids. Arch Ophthalmol 107:761–766

    PubMed  CAS  Google Scholar 

  13. Chang S (1994) Giant retinal tears: surgical management with perfluorocarbon liquids in medical and surgical retina. In: Lewis H, Ryan SJ (eds) Advances, controversies and management. Mosby, St. Louis, pp 199–207

    Google Scholar 

  14. Charteris DG (1995) Proliferative vitreoretinopathy: pathobiology, surgical management and adjunctive treatment. Br J Ophthalmol 79:953–960

    PubMed  CAS  Google Scholar 

  15. Charteris DG (1998) Cytokines in proliferative vitreoretinopathy. Br J Ophthalmol 82:106

    PubMed  CAS  Google Scholar 

  16. Charteris DG, Sethi CS, Lewis GP, Fisher SK (2002) Proliferative vitreoretinopathy — developments in adjunctive treatment and retinal pathology. Eye 16:369–374

    Article  PubMed  CAS  Google Scholar 

  17. Chignell AH, Fison LG, Davies EWG, Hartley RE, Gundry MF (1973) Failure in retinal detachment surgery. Br J Ophthalmol 57:525–530

    PubMed  CAS  Google Scholar 

  18. Colby K (1999) Management of open globe injuries. Int Ophthalmol Clin 39:59–69

    PubMed  CAS  Google Scholar 

  19. Cowley M, Conway BP, Campochiaro PA, Kaiser D, Gaskin H (1989) Clinical risk factors for proliferative vitreoretinopathy. Arch Ophthalmol 107:1147–1151

    PubMed  CAS  Google Scholar 

  20. Duquesne N, Bonnet M, Adeleine P (1996) Preoperative vitreous haemorrhage associated with rhegmatogenous retinal detachment: a risk factor for postoperative proliferative vitreoretinopathy? Graefes Arch Clin Exp Ophthalmol 234:677–682

    Article  PubMed  CAS  Google Scholar 

  21. Eckardt C, Eckardt U, Conrad H-G (1999) Macular rotation with and without counter-rotation of the globe in patients with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 237:313–325

    Article  PubMed  CAS  Google Scholar 

  22. El-Ghrably IA, Dua HS, Orr GM, Fischer D, Tighe P (1999) Detection of cytokine mRNA production in infiltrating cells in proliferative vitreoretinopathy using reverse transcription polymerase chain reaction. Br J Ophthalmol 83:1296–1299

    Article  PubMed  CAS  Google Scholar 

  23. Framme C, Roidr J (1999) Epidemiology of open globe injuries. Klin Monatsbl Augenheilkd 215:287–293

    PubMed  CAS  Google Scholar 

  24. Fujii GY, Pieramici DJ, Humayun MS, Schachat AP, Reynolds SM, Melia M, DeJuan E (2000) Complications associated with limited macular translocation. Am J Ophthalmol 130:751–762

    Article  PubMed  CAS  Google Scholar 

  25. Gartry DS, Chignell AH, Franks WA, Wong D (1993) Pars plana vitrectomy for the treatment of rhegmatogenous retinal detachment uncomplicated by advanced proliferative vitreoretinopathy. Br J Ophthalmol 77:199–203

    PubMed  CAS  Google Scholar 

  26. Gau M, Meier P, Wiedemann P (1999) Penetrating and perforating eye injuries with foreign bodies during motorized brush-cutting while wearing head protection gear. Klin Monatsbl Augenheilkd 215:311–314

    PubMed  CAS  Google Scholar 

  27. Girard P, Mimoun G, Karpouzas I, Montefiore G (1994) Clinical risk factors for proliferative vitreoretinopathy after retinal detachment surgery. Retina 14:417–424

    PubMed  CAS  Google Scholar 

  28. Glaser BM, Vidaurri-Leal J, Michels RG, Campochiaro PA (1993) Cryotherapy during surgery for giant retinal tears and intravitreal dispersion of viable retinal pigment epithelial cells. Ophthalmology 100:466–470

    PubMed  CAS  Google Scholar 

  29. Goffstein R, Burton T (1982) Differentiating traumatic from nontraumatic retinal detachment. Ophthalmology 89:361–368

    PubMed  CAS  Google Scholar 

  30. Greven CM, Sanders RJ, Brown GC, Annesley WH, Sarin LK, Tasman W, Morgan TM (1992) Pseudophakic retinal detachments. Anatomic and visual results. Ophthalmology 76:257–262

    Google Scholar 

  31. Heimann H, Bornfeld N, Friedrichs W, Helbig H, Kellner U, Korra A, Foerster MH (1996) Primary vitrectomy without scleral buckling for rhegmatogenous retinal detachment. Graefes Arch Clin Exp Ophthalmol 234:561–568

    Article  PubMed  CAS  Google Scholar 

  32. Jaffe GF, Schwartz D, Han DP, Gottleib M, Hartz A, McCarthy D, Mi WF, Abrams GW (1990) Risk factors for postvitrectomy fibrin formation. Am J Ophthalmol 109:661–667

    PubMed  CAS  Google Scholar 

  33. Johnson RN, Blankenship G (1988) A prospective randomised clinical trial of heparin therapy for postoperative intraocular fibrin. Ophthalmology 95:312–317

    PubMed  CAS  Google Scholar 

  34. Jonas JB, Budde WM (1999) Early versus late removal of retained intaocular foreign bodies. Retina 19:193–197

    Article  PubMed  CAS  Google Scholar 

  35. Kertes PJ, Wafapoor H, Peyman GA, Calixto N Jr, Thompson H (1997) The management of giant retinal tears using perfluoroperhydrophenanthrene. A multicenter case series.Vitreon Collaborative Study Group. Ophthalmology 104:1159–1165

    PubMed  CAS  Google Scholar 

  36. Kon CH, Asaria RH, Occleston NL, Khaw PT, Aylward GW (2000) Risk factors for proliferative vitreoretinopathy after primary vitrectomy: a prospective study. Br J Ophthalmol 84:506–511

    Article  PubMed  CAS  Google Scholar 

  37. Kreiger AE, Lewis H (1992) Management of giant retinal tears without scleral buckling. Use of radical dissection of the vitreous base and perfluorooctane and intraocular tamponade. Ophthalmology 99:491–497

    PubMed  CAS  Google Scholar 

  38. Lewis H, Aaberg TM, Abrams GW (1991) Causes of failure after initial vitreoretinal surgery for severe proliferative vitreoretinopathy. Am J Ophthalmol 111:8–14

    PubMed  CAS  Google Scholar 

  39. Lewis H, Aaberg TM (1991) Causes of failure after repeat vitreoretinal surgery for recurrent proliferative vitreoretinopathy. Am J Ophthalmol 111:15–19

    PubMed  CAS  Google Scholar 

  40. Machemer R, Aaberg TM, Freeman HM, et al (1991) An updated classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol 112:159–165

    PubMed  CAS  Google Scholar 

  41. Malbran E, Dodds R, Hulsbus R (1972) Traumatic retinal detachment. Mod Probl Ophthalmol 10:479–489

    PubMed  CAS  Google Scholar 

  42. Mittra RA, Mieler WF (1999) Controversies in the management of open-globe injuries involving the posterior segment. Surv Ophthalmol 3:215–225

    Article  Google Scholar 

  43. Morton C, MacKenzie F (1978) Retinal detachment due to ocular penetration. Arch Ophthalmol 96:1354–1361

    Google Scholar 

  44. Pastor JC (1998) Proliferative vitreoretinopathy: an overview. Surv Ophthalmol 43:3–18

    Article  PubMed  CAS  Google Scholar 

  45. Pertile G, Claes C (2002) Macular translocation with 360 degree retinotomy for management of age-related macular degeneration with subfoveal choroidal neovascularisation. Am J Ophthalmol 134:560–565

    Article  PubMed  Google Scholar 

  46. Rachal WF, Burton TC (1979) Changing concepts of failures after retinal detachment surgery. Arch Ophthalmol 97:480–483

    PubMed  CAS  Google Scholar 

  47. Salzmann J, Limb A, Khaw PT, Gregor ZJ, Webster L, Chignell AH, Charteris DG (2000) Matrix metalloproteinases and their natural inhibitors in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol 84:1090–1096

    Article  Google Scholar 

  48. Sarrafizadeh R, Hassan TS, Ruby AL, Williams GA, Garretson BR, Capone A, Trese MT, Margherio RR (2001) Incidence of retinal detachment and visual outcome in eyes presenting with posterior vitreous separation and dense fundus-obscuring vitreous haemorrhage. Ophthalmology 108:2273–2278

    Article  PubMed  CAS  Google Scholar 

  49. Schwartz SD, Kreiger AE (1998) Proliferative vitreoretinopathy: a natural history of the fellow eye. Ophthalmology 105:785–788

    Article  PubMed  CAS  Google Scholar 

  50. Sobaci G, Mutlu FM, Bayer A, Karagui S, Yildirim E (2000) Deadly weapon-related open-globe injuries: outcome assessment by the ocular trauma classification system. Am J Ophthalmol 129:47–53

    Article  PubMed  CAS  Google Scholar 

  51. Speicher MA, Fu AD, Martin JP, von Fricken MA (2000) Primary vitrectomy alone for repair of retinal detachments following cataract surgery. Retina 20:459–464

    Article  PubMed  CAS  Google Scholar 

  52. Spiegel D, Nasemann J, Nawrocki J, Gabel VP (1997) Severe ocular trauma managed with primary pars plana vitrectomy and silicone oil. Retina 17:275–285

    PubMed  CAS  Google Scholar 

  53. The Retina Society Terminology Committee (1983) The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology 90:121–125

    Google Scholar 

  54. The Silicone Study Group (1992) Vitrectomy with silicone oil or sulfur hexafluoride gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Arch Ophthalmol 110:770–779

    Google Scholar 

  55. The Silicone Study Group (1992) Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Arch Ophthalmol 110:780–792

    Google Scholar 

  56. Verstraeten T, Williams GA, Chang S, Cox MS Jr, Trese MT, Moussa M, Friberg TR (1995) Lenssparing vitrectomy with perfluorocarbon liquid for the primary treatment of giant retinal tears. Ophthalmology 102:17–20

    PubMed  CAS  Google Scholar 

  57. Viduarri-Leal JS, Glaser BM (1984) Effect of fibrin on morphological characteristics of retinal pigment epithelial cells. Arch Ophthalmol 102:1376–1379

    Google Scholar 

  58. Wiedemann P, Lemmen K, Schmiedl K, Heimann K (1987) Intraocular daunomycin for the treatment and prophylaxis of traumatic proliferative vitreoretinopathy. Am J Ophthalmol 104:10–14

    PubMed  CAS  Google Scholar 

  59. Wiedemann P, Leinung C, Hilgers RD, Heimann K (1991) Daunomycin and silicone oil for the treatment of proliferative vitreoretinopathy. Graefes Archiv Exp Ophthalmol 229:150–153

    CAS  Google Scholar 

  60. Wiedemann P, Hilgers RD, Bauer P, Heimann K (1998) Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trial. Am J Ophthalmol 126:550–559

    Article  PubMed  CAS  Google Scholar 

  61. Williams RG, Chang S, Comaratta MR, Simoni G (1996) Does the presence of heparin and dexamethasone in the vitrectomy infusate reduce reproliferation in proliferative vitreoretinopathy? Graefes Arch Clin Exp Ophthalmol 234:496–503

    Article  PubMed  CAS  Google Scholar 

  62. Wong TY, Tielsch JM (1999) A population-based study on the incidence of severe ocular trauma in Singapore. Am J Ophthalmol 128:345–351

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Moorfields Eye Hospital, City Road, London, EC1V 2PD, UK

    David G. Charteris MD (Consultant Ophthalmologist)

Authors
  1. David G. Charteris MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Ophthalmology, University of Cologne, Joseph-Stelzmann-Straße 9, 50931, Cologne, Germany

    Bernd Kirchhof MD (Professor of Ophthalmology) (Professor of Ophthalmology)

  2. St. Paul’s Eye Unit, Royal Liverpool University Hospital, Prescot Street, Liverpool, L7 8XP, UK

    David Wong MD (Consultant Ophthalmologist) (Consultant Ophthalmologist)

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Charteris, D.G. (2005). Prevention of Proliferative Vitreoretinopathy. In: Kirchhof, B., Wong, D. (eds) Vitreo-retinal Surgery. Essentials in Ophthalmology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27152-X_9

Download citation

  • DOI: https://doi.org/10.1007/3-540-27152-X_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-20044-4

  • Online ISBN: 978-3-540-27152-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation